NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,797,161 | -0.1% | 675,409 | -1.0% | 1.36% | +4.1% |
| Q2 2023 | $68,874,102 | +9.0% | 682,530 | -0.7% | 1.30% | +0.4% |
| Q1 2023 | $63,205,932 | +2.0% | 687,021 | +0.6% | 1.30% | -11.9% |
| Q4 2022 | $61,980,176 | +20.0% | 683,203 | +0.5% | 1.48% | +14.3% |
| Q3 2022 | $51,662,000 | -11.4% | 679,666 | -1.5% | 1.29% | -9.6% |
| Q2 2022 | $58,317,000 | -6.2% | 689,894 | -2.6% | 1.43% | +15.6% |
| Q1 2022 | $62,181,000 | -2.0% | 708,618 | -2.3% | 1.24% | +12.7% |
| Q4 2021 | $63,458,000 | +5.7% | 725,480 | -1.2% | 1.10% | -2.2% |
| Q3 2021 | $60,046,000 | -11.7% | 734,244 | -1.5% | 1.12% | -10.2% |
| Q2 2021 | $67,998,000 | +5.9% | 745,268 | -0.8% | 1.25% | -4.8% |
| Q1 2021 | $64,199,000 | -9.9% | 751,044 | -0.5% | 1.31% | -10.7% |
| Q4 2020 | $71,268,000 | +8.4% | 754,725 | -0.1% | 1.47% | -1.3% |
| Q3 2020 | $65,726,000 | +0.1% | 755,822 | +0.6% | 1.49% | -8.5% |
| Q2 2020 | $65,644,000 | +3.6% | 751,583 | -2.2% | 1.63% | -17.4% |
| Q1 2020 | $63,337,000 | -14.0% | 768,181 | -1.3% | 1.97% | +10.9% |
| Q4 2019 | $73,677,000 | +8.6% | 778,084 | -0.3% | 1.78% | +1.1% |
| Q3 2019 | $67,823,000 | -5.4% | 780,464 | -0.6% | 1.76% | -5.1% |
| Q2 2019 | $71,678,000 | -6.0% | 784,993 | -1.1% | 1.85% | -9.6% |
| Q1 2019 | $76,273,000 | +11.5% | 793,344 | -0.5% | 2.05% | -4.6% |
| Q4 2018 | $68,394,000 | -6.0% | 797,036 | -5.6% | 2.15% | +11.6% |
| Q3 2018 | $72,752,000 | +12.8% | 844,382 | -1.1% | 1.92% | +5.4% |
| Q2 2018 | $64,486,000 | -6.3% | 853,665 | +0.3% | 1.83% | -6.5% |
| Q1 2018 | $68,836,000 | -5.2% | 851,402 | -1.5% | 1.95% | -5.0% |
| Q4 2017 | $72,583,000 | -6.6% | 864,497 | -4.5% | 2.06% | -8.4% |
| Q3 2017 | $77,745,000 | -1.2% | 905,586 | -3.9% | 2.24% | -2.9% |
| Q2 2017 | $78,675,000 | -0.0% | 942,560 | -11.1% | 2.31% | +6.6% |
| Q1 2017 | $78,705,000 | +28.9% | 1,059,717 | +26.4% | 2.17% | +26.1% |
| Q4 2016 | $61,074,000 | -10.9% | 838,467 | -3.4% | 1.72% | -8.7% |
| Q3 2016 | $68,559,000 | +5.6% | 868,278 | +10.4% | 1.88% | +2.7% |
| Q2 2016 | $64,898,000 | +7.7% | 786,548 | -5.4% | 1.83% | +12.5% |
| Q1 2016 | $60,235,000 | -18.7% | 831,513 | -3.4% | 1.63% | -16.4% |
| Q4 2015 | $74,056,000 | -8.9% | 860,714 | -2.7% | 1.95% | -10.2% |
| Q3 2015 | $81,277,000 | -19.9% | 884,218 | -14.4% | 2.17% | -0.1% |
| Q2 2015 | $101,527,000 | -7.6% | 1,032,404 | -7.3% | 2.17% | -1.2% |
| Q1 2015 | $109,861,000 | -3.9% | 1,114,097 | -9.7% | 2.20% | +5.9% |
| Q4 2014 | $114,309,000 | -4.1% | 1,233,637 | -2.6% | 2.08% | -3.0% |
| Q3 2014 | $119,220,000 | +0.0% | 1,266,543 | -3.8% | 2.14% | +6.2% |
| Q2 2014 | $119,170,000 | +4.1% | 1,316,359 | -2.2% | 2.02% | +0.7% |
| Q1 2014 | $114,450,000 | +4.5% | 1,346,152 | -1.2% | 2.00% | +3.1% |
| Q4 2013 | $109,504,000 | +0.9% | 1,362,324 | -3.7% | 1.94% | -4.3% |
| Q3 2013 | $108,484,000 | +0.8% | 1,414,213 | -7.1% | 2.03% | +3.3% |
| Q2 2013 | $107,639,000 | – | 1,522,254 | – | 1.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |